Notice of Registration - 2013
[Federal Register Volume 78, Number 17 (Friday, January 25, 2013)]
[Notices]
[Pages 5499-5500]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01603]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Johnson Matthey, Inc.
By Notice dated May 9, 2012, and published in the Federal Register
on May 21, 2012, 77 FR 30026, Johnson Matthey, Inc., Custom
Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey
08066-1742, made application by letter to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of
Tapentadol (9780), a basic class of controlled substance listed in
schedule II.
The company plans to manufacture the listed controlled substance
for sale to its customers.
One comment objecting to the granting of registration as a bulk
manufacturer of the basic class of controlled substance listed to this
applicant was received. However, after a thorough review of this
matter, DEA has concluded that the issues raised in the comment and
objection do not warrant the denial of this application.
DEA has considered the factors in 21 U.S.C. 823(a) and determined
that the registration of Johnson Matthey, Inc., to manufacture the
listed basic class of controlled substance is consistent with the
public interest at this time. DEA has investigated Johnson Matthey,
Inc., to ensure that the company's registration is consistent with the
public interest. The
[[Page 5500]]
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic class of controlled substance listed.
Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-01603 Filed 1-24-13; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
